SUMMARY
branches. Subsequently, the internal carotid, and the occipital, superior thyroid and ascending pharyngeal branches were ligated, leaving the remaining branches (lingual, external maxillary and posterior auricular) available for infusion.
A cannula was placed in the common carotid artery in the direction of the head distal to the carotid sinus and made secure. It was connected to a Y-shaped plastic tube, one arm of which was used for the constant infusion of solutions at a speed of 0.05 ml min" 1 (Braun Melsungen AG constant speed infusion pump); the other was connected to a physiological pressure transducer (4-422 Bell and Howell). In this rigid system, under constant infusion rates, pressure changes recorded by the transducer reflected changes in vascular resistance.
At the distal end of the Y-tube, a three-way tap allowed for the administration of measured injections of fluid. Arterial pressure (and heart rate) were obtained via a second pressure transducer connected to a cannula placed in the common carotid artery in the direction of the heart. Measurements were amplified electronically and registered on paper (Lectromed MX-212 amplifier and pen recorder). Following tracheal intubation, the skin incision was sewn back and time allowed for the attainment of stable values of arterial pressure and vascular resistance. Arterial pressure (AP) was monitored (a) to assess the condition of the preparation; a decrease in AP of more than 20% of its original value led to the rejection of the preparation and, (b) to ensure that AP was stable before an injection or infusion. Injections of adrenaline led to a small and transient increase in AP; no systematic study of these changes was attempted. An overhead electric bulb provided the heat to maintain the rectal temperature at 37 °C. At the end of the investigation the animal was sacrificed with an overdose of barbiturate.
Drugs and procedure
Solutions of lignocaine hydrochloride were made up on the day of the study from stock 1 % solutions prepared from the crystalline form (Astra Chemicals). Doses of adrenaline were prepared using adrenaline 1 mg ml" 1 (Antigen Ltd). Hartmann's solution (compound sodium lactate injection BP, Travenol Laboratories Ltd) was used as the infusion vehicle. At the start of each study a constant infusion of Hartmann's solution was established and a stable value of vascular resistance recorded. Solutions of adrenaline were then administered as bolus injections, to establish the range of arterial responsiveness; after interruption of the constant infusion, adrenaline 20, 40, 80 and 120 ng in Hartmann's solution 0.1 ml was introduced to the arteries via the three-way tap. The re-establishment of the infusion ensured the passage of the adrenaline solution through the arteries. The order in which the doses of adrenaline were administered was rotated to cancel out possible sensitizing effects of adrenaline on smooth muscle.
Following recovery of the steady state of vascular resistance, the infused medium was substituted, for a 10-min period, by a solution of lignocaine hydrochloride in concentrations of 10, 100 or 1000 ug ml" 1 in Hartmann's solution, equivalent to lignocaine 0.5, 5 or 50 ug min" 1 . Each preparation was used for the administration of only one infusion of lignocaine. The infusion finally reverted to Hartmann's solution and the vascular response to adrenaline was obtained at this point and 1 h later.
Data collection and statistical analysis
Results are presented as the mean maximum change in arterial resistance in mm Hg ± standard error of mean (SEM). Statistical analysis was performed using the paired-sample t test. As this test is applicable only when the data compared possess equal variances, a variance ratio test was performed initially. This yielded one case of significantly different variances and to that the Fischer-Behrens test was applied (Fischer and Yates, 1957; Campbell, 1967) .
RESULTS
Eighteen individual investigations were performed, six each for the three lignocaine concentrations used. Average values for arterial pressure before the infusion of lignocaine were: systolic 85.4±8.0 mm Hg; diastolic 36.2±3.1 mm Hg.
Average vascular resistance of the preparation at steady state (that is when only physiological medium was infused) was 13.8 ±3.7 mm Hg.
Effects of lignocaine infusions on vascular resistance
Arterial infusions of lignocaine, in the doses described above, had no effect on arterial pressure and did not induce any changes in vascular resistance. In seven separate studies the lignocaine concentration was increased to 2000 ug ml" 1 , the rate of infusion was doubled and its duration extended beyond 10 min. In five of these studies, vascular resistance increased after an average of 15 min. This was accompanied by marked decreases in arterial pressure and respiratory rate, indicating that the observed constriction was likely to be the consequence of the effects of lignocaine on cardiac muscle and the central nervous system.
Effects of lignocaine on the vascular response to adrenaline
Following the infusion of lignocaine, the response of the vascular bed to adrenaline was inhibited significantly by all three doses of lignocaine (table I) . Recovery of the ability of the vascular bed to respond to the administration of adrenaline, tested 60 min after the termination of the lignocaine infusion, decreased as the concentration of that infusion increased (table I) . 
DISCUSSION
We believe this to be the first in vivo demonstration of the inhibitory effects of i.a. infused lignocaine on the vasoconstriction produced by adrenaline. This inhibition was shown to persist beyond the termination of the infusion of lignocaine in a dose-related way. Similar effects of lignocaine have been reported on isolated peripheral vessels (Gerke, Frewin and Frost, 1976) and aortic strips (Astrom, 1964; Fleisch and Titus, 1973) suggesting considerable catecholamine-lignocaine antagonism in vascular smooth muscle. Such antagonism probably holds true for most local anaesthetics in vitro (Fleckenstein, 1952; Astrom, 1964) . Our preliminary in vivo investigations on two other common amide local anaesthetics, prilocaine and mepivacaine, produced results similar to those obtained with lignocaine.
It has been reported that low concentrations of lignocaine (25 and 145 ug ml" 1 ) potentiated rather than inhibited the effect of adrenaline on aortic strips (Astrom, 1964; Nava Riviera et al., 1967) . This may be a specific effect on aortic muscle as, in our study which utilized the vascular system of the head, no such potentiation was observed with comparable concentrations (10 or 100 ug ml" 1 ).
The inhibition of adrenergic vasoconstriction by lignocaine has been ascribed to a-adrenergic antagonism (Fleisch and Titus, 1973) , but could equally well be the result of a non-specific anti-adrenaline effect. Local anaesthetics are likely to interfere directly with the contractile effect of Ca 8+ on smooth muscle cells, thus side-stepping specific receptor sites; the Ca 1+ -binding regulatory protein, calmodulin, also binds lignocaine in a Ca f+ -dependent manner and, in vitro, calmodulinactivated enzymatic systems have been shown to be inhibited by local anaesthetics (Schaub, Watterson and Waser, 1983) . Moreover, the possibility that lignocaine acts specifically on a-adrenergic receptors would be reasonably excluded if it were shown that lignocaine also inhibited the function of histamine receptors in a manner analogous to that reported here. Our preliminary observations indicate this to be the case.
A simple answer to the question " is lignocaine a peripheral vasodilator? " may not be possible. Its intravascular administration in man is responsible for peripheral vasodilatation (Blair, 1975) , but this should be qualified by other findings, also reviewed by Blair, which point in the opposite direction.
In the investigation described here we did not observe any lignocaine-associated vasodilatation in the absence of adrenaline-induced constriction. It could be argued that the basal tone of the vascular muscle in this preparation was too low. However, the assumption of at least some degree of basal tone, especially in the more distal parts of the carotid vascular tree, would not be unreasonable, especially when we consider that the nerve supply to these vessels remained intact. Arguing from this basis and bearing in mind that a 10 |ig ml~l lignocaine infusion inhibited adrenaline-induced vasoconstriction, it is of some note that infusions of lignocaine of up to 100 times the above concentration possessed no direct vasodilatory activity whatsoever; in this preparation the action of lignocaine was limited to countering the constriction produced by adrenaline.
